Background Image
Table of Contents Table of Contents
Previous Page  93 / 52 Next Page
Basic version Information
Show Menu
Previous Page 93 / 52 Next Page
Page Background

93

María Jesús Chaves-Samaniego

La terapia con célulasmadre en retina

2.

Klein R, Klein B, Jensen SC, Cruickshanks KJ. The relationship of

ocular factors to the incidence and progression of age-related

maculopathy. ArchOphthalmol. 1998; 116(4):506–513.

3.

Strauss O. The retinal pigment epithelium in visual function. Physiol.

Rev. 2005; 85: 845-881.

4.

Strauss O. Die Rolle des retinalen Pigmentepithels im Rahmen

visueller Funktionen. Der Ophthalmologe. 2009; 106: 299-304

5.

Klein R, Peto T, Bird A, Vannewkirk MR. The epidemiology of age-

relatedmaculardegeneration.AmJOphthalmol.2004;137:486–95.

6.

Haddad S, Chen CA, Santangelo SL, Seddon JM. The genetics of age-

related macular degeneration: a review of progress to date. Surv

Ophthalmol. 2006; 51:316-63.

7.

Zarbin MA. Current concepts in the pathogenesis of age related

macular degeneration. ArchOphthalmol. 2004; 122:598-614. 

8.

Nowak JZ. Age-related macular degeneration (AMD): pathogenesis

and therapy. Pharmacol Rep. 2006; 58 (3): 353-63.

9.

Fernández-Robredo P, Sancho A, Johnen S, et al. Current Treatment

Limitations in Age-Related Macular Degeneration and Future

Approaches Based on Cell Therapy and Tissue Engineering. J

Ophtalmol. 2014; 2014:510285.

10. Walia S, Fishman GA. Natural history of phenotypic changes in

Stargardt macular dystrophy. Ophthalmic Genet. 2009; 30: 63-68.

11. Ritter M, Zotter S, Schmidt WM, et al. Characterization of stargardt

disease using polarization-sensitive optical coherence tomography

and fundus autofluorescence imaging. Invest Ophthalmol Vis Sci.

2013; 54 (9): 6416-25.

12. Blanco MJ, Capeans C. Retinitis pigmentaria. Med Clin. 2001;

117:135-6.

13. Hamel C. Retinitis pigmentosa. Orphanet J Rare Dis. 2006; 1:40.

14. Reubinoff BE, PeraMF, Fong C, et al. Embryonic stem cell lines from

human blastocysts: somatic differentiation in vitro. Nat. Biotechnol.

2000; 18: 399 – 404. 

15. Bharti K, Rao M, Hull SC, et al. Developing cellular therapies for

retinal degenerative diseases. Invest Ophthalmol Vis Sci. 2014; 55

(2): 1191-202.

16. Ramsden CM, Powner MB, Carr AJ, Smart M, da Cruz L, Coffery

PJ. Stem cells in retinal regeneration: past, present and future.

Development. 2013; 140: 2576-2585.

17. Binder S, Krebs I, Hilgers RD, et al. Outcome of transplantation

of autologous retinal pigment epithelium in age-related macular

degeneration: a prospective trial. Invest Ophtalmol Vis Sci. 2004; 45

(11): 4151-60.

18. Chen FK., Patel PJ, Uppal GS, Tufail A, Coffey PJ, da Cruz L. Long-

term outcomes following full macular translocation surgery in

neovascular age-related macular degeneration. Br J Ophthalmol.

2010; 94 (10): 1337-1343.

19. Vugler A, Carr A.-J, Lawrence J, et al. Elucidating the phenomenon

of HESC-derived RPE: anatomy of cell genesis, expansion and retinal

transplantation. ExpNeurol. 2008; 214: 347-361. 

20. Thumann G, Viethen A, Gaebler A, et al. The in vitro and in vivo

behaviour of retinal pigment epitelial cells culture don ultrathin

collagenmembranes. Biomaterials. 2009; 30: 287-294.

21. Sistiabudi R, Paderi J, Panitch A, Ivanisevic A. Modification of native

collagenwith cell-adhesive peptide to promote RPE cell attachment

onBruch’smembrane. Biotechnol Bioeng. 2009; 102(6):1723–1729. 

22. Meyer JS, Shearer RL, Capowski EE, et al. Modeling early retinal

development with human embryonic and induced pluripotent stem

cells. Proc Natl Acad Sci. 2009; 106: 16698-16703. 

23. Idelson M, Alper R, Obolensky A, et al. Directed differentiation

of human embryonic stem cells into functional retinal pigment

epitheliumcells. Cell StemCell. 2009; 5: 396-408. 

24. Schwartz SD, Regillo CD, Lam BL, et al. Human embryonic stem

cell-derived retinal pigment epithelium in patients with age-related

macular degeneration and Stargardt’s macular dystrophy: follow-up

of two open-label phase 1/2 studies. Lancet. 2015; 385 (9967): 509-

16.

25. McGill TJ, Cottam B, Lu B, et al. Transplantation of human

central nervous system stem cells – neuroprotection in retinal

degeneration. Eur J Neurosci. 2012; 35: 468-477. 

26. MacLaren RE, Pearson RA, MacNeil A, et al. Retinal repair by

transplantation of photoreceptor precursors. Nature. 2006;

444: 203-207. 

27. Lamba DA, Karl MO, Ware CB, Reh TA. Efficient generation of retinal

progenitor cells from human embryonic stem cells. Proc Natl Acad

Sci. 2006; 103: 12769-12774. 

28. ZhuD,DengX,SpeeC,etal.PolarizedsecretionofPEDFfromhuman

embryonic stem cell-derived RPE promotes retinal progenitor cell

survival. Invest Ophthalmol Vis Sci. 2011; 52: 1573-1585.

29. Lund RD,Wang S, Lu B, et al. Cells isolated fromumbilical cord tissue

rescue photoreceptors and visual functions in a rodent model of

retinal disease. StemCells. 2007; 25: 602-611. 

30. Atmaca-Sonmez P, Li Y, Yamauchi Y, et al. Systemically transferred

hematopoietic stem cells home to the subretinal space and express

RPE-65inamousemodelofretinalpigmentepitheliumdamage.Exp

Eye Res. 2006; 83: 1295-1302.

31. Park SS, Caballero S, Bauer G, et al. Long-term effects of intravitreal

injection of GMP-grade bone-marrow-derived CD34+ cells in NOD-

SCIDmicewithacuteischemia-reperfusioninjury.InvestOphthalmol

Vis Sci. 2012; 53: 986-994.

32. Siqueira RC, Messias A, Voltarelli JC, Scott IU, Jorge R. Intravitreal

injection of autologous bonemarrow-derivedmononuclear cells for

hereditary retinal dystrophy: a phase I trial. Retina. 2011; 31: 1207-

1214. 

33. Siqueira RC, Messias A, Gurgel VP, Simões B P, Scott IU, Jorge R.

Improvement of ischaemic macular oedema after intravitreal

injection of autologous bonemarrow-derived haematopoietic stem

cells. Acta Ophthalmol. 2015; 93: e174–e176.

34. Buchholz DE, Hikita ST, Rowland TJ, et al. Derivation of Functional

Retinal Pigmented Epithelium from Induced Pluripotent Stem Cells.

StemCells. 2009; 27: 2427–2434.

35. Chacon-Camacho OF, Zenteno JC. Review and update on the

molecular basis of Leber congenital amaurosis. World J Clin Cases.

2015; 3 (2): 112-24.

36. Carr AJF, SmartMJK., Ramsden CM, PownerMB, da Cruz L, Coffey P.

J. Development of human embryonic stem cell therapies for age-

relatedmacular degeneration. Trends Neurosci. 2013; 36: 385-95.

37. Coffey P, da Cruz L. The London Project to Cure Blindness. The

Project.[citadoel1dejuniode2014

]http://www.thelondonproject.

org/?q=project/about-us.